Me CEO Anne Wojcicki talks to "CBS Mornings" co-host Gayle King about the company's recent struggles, welcoming employee feedback and her vision for the future of the genetic-testing and ...

Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.

It was a simple process. You’d collect a saliva sample, ship it off, and within six weeks, you’d receive a complete ancestral ...

In an exclusive interview with "CBS Mornings" co-host Gayle King, 23andMe CEO Anne Wojcicki discusses the challenges of ...

23andMe CEO Anne Wojcicki discusses the company's future following a major data security incident that led to a $30 million ...

Wojcicki believes that the company is ‘viable’ and ‘transforming’ under her. King redirected Wojcicki from her initial corporate boilerplate-speak twice within the first few minutes back to the ...

Anne Wojcicki, the embattled CEO of genetic testing company 23andMe sat down with "CBS Mornings" co-host Gayle King to ...

23andMe, the struggling ancestry tracing ... what could happen to its sensitive customer genetic testing data. CEO Anne Wojcicki has said she intends to take the company private and is not ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Sisters of former YouTube CEO Susan Wojcick, who died of lung cancer earlier this year, are raising awareness for early ...

NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.